Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3450
-0.0160 (-4.43%)
At close: Jun 11, 2026
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 100.71 million as of June 11, 2026. Its market cap has increased by 22.31% in one year.
Market Cap
100.71M
Enterprise Value
17.32M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 100.71M, a decrease of -52.04%. That is a compound annual growth rate of -7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 105.38M | -2.43% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 158.16M |
| Alligator Bioscience AB | 126.88M |
| NextCell Pharma AB | 120.30M |
| Simris Group AB (PUBL) | 116.62M |
| IRLAB Therapeutics AB | 105.32M |
| OncoZenge AB | 99.60M |
| AcouSort AB | 95.87M |
| Scandinavian ChemoTech AB | 92.14M |